HALB News and Press, Tykhe Corp From 07/20/22

Halberd ( OTCPK:HALB ) has announced the formation of Halberd Cancer Therapeutics, as a wholly owned subsidiary. Halberd's patented extracorporeal technology has demonstrated the capacity for successful application to a wide variety of diseases and health-related illnesses. ...

JACKSON CENTER, PA / ACCESSWIRE / July 20, 2022 / Halberd Corporation (OTC PINK:HALB) announced the formation of Halberd Cancer Therapeutics, LTD, as a wholly owned subsidiary. Halberd's patented extracorporeal technology has demonstrated the capacity for successful application to a wide v...

Boosts Effectiveness of Commercial Covid Antibodies by 45% Jackson Center, Pennsylvania--(Newsfile Corp. - July 14, 2022) - Halberd Corporation (OTC Pink: HALB) researchers developed, with appropriate protocols, a SARS-CoV-2 antibody effective against all four Covid-19 mutations currently in ...

Boosts Effectiveness of Commercial Covid Antibodies by 45% JACKSON CENTER, PA / ACCESSWIRE / July 14, 2022 / Halberd Corporation (OTC PINK:HALB) researchers developed, with appropriate protocols, a SARS-CoV-2 antibody effective against all four Covid-19 mutations currently in circulat...

Q2 Accomplishments and a Look to the Future Jackson Center, Pennsylvania--(Newsfile Corp. - July 12, 2022) - Halberd Corporation (OTC Pink: HALB) This past quarter has witnessed some very significant technical and organizational achievements by the Halberd team. The accomplishments for the ...

Halberd Corporation (OTC PINK: HALB), after recognizing the depth of application of its recently patented extracorporeal treatment approach, has announced the creation of a new subsidiary. The subsidiary comprises a group of researchers focusing on cancer treatment. The techno...

Halberd Corp (OTCPK:HALB) said on Tuesday it had created a subgroup of researchers to focus on cancer treatment and expects the new cancer subgroup to eventually be spun off as a separate company. The company said the subgroup will be guided by its existing technical team members. T...

JACKSON CENTER, PA / ACCESSWIRE / June 21, 2022 / Recognizing the breadth of application of its patented extracorporeal treatment approach, Halberd Corporation (OTC PINK:HALB) announced the creation of a subgroup of researchers to focus on cancer treatment. Halberd's technology is capable ...

Jackson Center, Pennsylvania--(Newsfile Corp. - June 8, 2022) - Halberd Corporation (OTC Pink: HALB) and Mississippi State University (MSU) executed a non-disclosure agreement (NDA) to explore animal testing as the next step in obtaining FDA certification for Halberd's patented extracorporeal ...

JACKSON CENTER, PA / ACCESSWIRE / June 8, 2022 / Halberd Corporation (OTC PINK:HALB) and Mississippi State University (MSU) executed a non-disclosure agreement (NDA) to explore animal testing as the next step in obtaining FDA certification for Halberd's patented extracorporeal disease erad...